Mice treated with IL-17A knockout or IL-17A monoclonal antibody exhibited significantly reduced cardiac remodeling and myocardial fibrosis post-myocarditis, and absence of DCM (78). This evidence concerns the gene IL17A and familial dilated cardiomyopathy.